Evidence map›Paper›PMID 26319397›Full record

ArticleBMC medical genetics2015

LOXL1 gene variants and their association with pseudoexfoliation glaucoma (XFG) in Spanish patients.

Lydia Álvarez, Montserrat García, Héctor González-Iglesias, Julio Escribano, Pedro P Rodríguez-Calvo, Luis Fernández-Vega, Miguel Coca-Prados

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Association ofInternational journal of ophthalmology · 2018
    Article
  6. LncRNAs in genetic basis of glaucoma.BMJ open ophthalmology · 2018
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lydia ÁlvarezFundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, Avenida Doctores Fernández-Vega, 34, Oviedo, 33012, Spain. l.alvarez@fio.as.
Montserrat GarcíaFundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, Avenida Doctores Fernández-Vega, 34, Oviedo, 33012, Spain. mgarciadiaz@fio.as.
Héctor González-IglesiasFundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, Avenida Doctores Fernández-Vega, 34, Oviedo, 33012, Spain. h.gonzalez@fio.as.
Julio EscribanoLaboratorio de Genética Molecular Humana, Facultad de Medicina/Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, 02006, Spain. julio.escribano@uclm.es.
Pedro P Rodríguez-CalvoFundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, Avenida Doctores Fernández-Vega, 34, Oviedo, 33012, Spain. pprcalvo@fernandez-vega.com.
Luis Fernández-VegaFundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, Avenida Doctores Fernández-Vega, 34, Oviedo, 33012, Spain. prof.luis@fernandez-vega.com.
Miguel Coca-PradosFundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, Avenida Doctores Fernández-Vega, 34, Oviedo, 33012, Spain. Miguel.Coca-Prados@yale.edu.
Fernández-Vega Ophthalmological Institute · ESUniversity of Castilla-La Mancha · ESYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLOXL1 gene is the most important genetic risk factor known so far for pseudoexfoliation glaucoma (XFG). Our purpose was to evaluate the potential association of individual genetic variants of the lysyl oxidase-like 1 (LOXL1) gene and haplotypes with XFG in Spanish patients.

methodsBlood samples were collected from a total of 105 Spanish patients with XFG and 200 healthy controls. The entire LOXL1 gene along with the promoter, coding and non-coding regions including the 5'- and 3'-untranslated regions, were sequenced using next-generation sequencing in 99 XFG patients. SNPs rs16958477 (promoter), rs1048661 (exon 1), rs3825942 (exon 1), rs2165241 (intron 1) and rs3522 (exon 7) in LOXL1 were genotyped by restriction fragment-length polymorphism (RFLP) in all Spanish control participants and in six additional XFG patients, and a case-control association study was performed. Comparisons of the allelic and genotypic frequencies were performed using standard χ(2) test with Bonferroni and Pearson corrections. Logistic regression analyses were permormed using Sigmaplot v11. Haplotypes frequencies were performed using HaploView 4.0.

resultsSequencing of the LOXL1 gene in XFG participants identified a total of 212 SNPs, of which 49 exhibited allelic frequencies with significant differences between cases and controls, and 66 were not previously described. The allele frequencies of SNPs rs16958477, rs1048661, rs3825942, rs2165241, were significantly associated with an increased risk for XFG, however the SNP rs3522 was not. The haplotype frequencies of SNPs rs16958477, rs1048661, rs3825942 and rs2165241 and their association with XFG indicated that the CGGT haplotype, containing all four risk alleles, and the AGGT haplotype, which carries the protective allele of rs16958477 and three risk alleles of the other three SNPs, were significantly associated with XFG (p = 4.5×10(-6), and p = 8.8×10(-6)), conferring more than 2-fold increased disease susceptibility.

conclusionsSNPs of the LOXL1 gene are associated with XFG in the Spanish population. This information adds new support to the distinct risk association frequencies of LOXL1 alleles with XFG in Western European and Asian populations. Identification and validation of additional SNPs along the entire LOXL1 gene of XFG cases may provide insightful information on their potential role in the pathogenesis of this disease.

Indexed as

Amino Acid OxidoreductasesBase SequenceExfoliation SyndromeGene FrequencyHumansLogistic ModelsMolecular Sequence DataPolymorphism, Restriction Fragment LengthPolymorphism, Single NucleotideSequence Analysis, DNASpainAmino Acid OxidoreductasesLOXL1 protein, human

Identifiers

PMID26319397
PMCPMC4593192
OpenAlexW1914374322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.